Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Conserved Binding Sites

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...

Protein-Drug Binding: Determination Methods

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...

Drug-Receptor Bonds

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...

Ligand Binding and Linkage

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hydrosilafluorenes as Recyclable Coupling Reagents for Direct Amidation of Carboxylic Acids with Amines.

Organic letters·2025

Same author

Evaluating the Aqueous Stability of Alkyl-/Aryl-Hydrosilanes by NMR Spectroscopy and GC-MS.

ChemPlusChem·2025

Same author

Design, synthesis, and antitumor efficacy of novel 5-deazaflavin derivatives backed by kinase screening, docking, and ADME studies.

Journal of enzyme inhibition and medicinal chemistry·2023

Same author

Direct Alkylative Amination Using 1-Allylsilatrane.

Chemistry (Weinheim an der Bergstrasse, Germany)·2023

Same author

Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics.

Cells·2023

Same author

Direct photochemical route to azoxybenzenes <i>via</i> nitroarene homocoupling.

Organic & biomolecular chemistry·2022

Search research articles

Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

Classifying covalent protein binders by their targeted binding site.

Walaa A Bedewy¹, John W Mulawka², Marc J Adler²

¹Department of Chemistry & Biology, Toronto Metropolitan University, Toronto, ON M5B 2K3, Canada; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Egypt.

Bioorganic & Medicinal Chemistry Letters

|December 12, 2024

Summary

This summary is machine-generated.

Covalent protein binders are now recognized as safe and effective therapeutics, offering advantages like enhanced potency and resistance to mutations. This review explores their diverse binding sites and applications in drug discovery.

Keywords:

Covalent drugs Protein binders

More Related Videos

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Jun 5, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Published on: February 28, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

Biochemistry
Medicinal Chemistry
Drug Discovery

Background:

Covalent protein targeting offers precise control over protein function but faced historical safety concerns regarding off-target toxicity.
Recent advancements have established covalent binders as safe, potent, and long-acting therapeutics with improved selectivity.
These molecules overcome challenges like mutation-induced resistance and achieve higher efficacy than non-covalent drugs.

Purpose of the Study:

To review the different classes of binding sites amenable to covalent modification on target proteins.
To elucidate the principles governing selective covalent targeting based on binding pocket and warhead characteristics.
To showcase the versatile applications of covalent protein binders in modern drug discovery through case studies.

Main Methods:

Review of existing literature on covalent protein binders and their mechanisms.
Analysis of protein structure and binding site properties influencing covalent modification.
Case study analysis of recently developed covalent binders and their therapeutic applications.

Main Results:

Proteins present diverse binding pockets suitable for covalent modification.
Selective targeting is achieved by optimizing the interplay between binding site geometry/physicochemistry and covalent modifier (warhead) reactivity.
Covalent binders can modulate protein conformation to inhibit or enhance activity, demonstrating broad therapeutic potential.

Conclusions:

Covalent protein binders are versatile tools in drug discovery, offering enhanced potency, selectivity, and resistance management.
Understanding the nuances of binding site interactions and warhead design is crucial for developing safe and effective covalent therapeutics.
The strategic application of covalent binders opens new avenues for treating diseases and advancing pharmaceutical research.